Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial

Michael P. Pender, Rajiv Khanna, Corey Smith et al.|Queensland's institutional digital repository (The University of Queensland)|2017

Cited by 0